Smith Hayes Advisers’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$337K Hold
17,910
0.07% 240
2015
Q4
$330K Hold
17,910
0.07% 240
2015
Q3
$294K Hold
17,910
0.06% 243
2015
Q2
$317K Buy
17,910
+1,660
+10% +$29.7K 0.06% 248
2015
Q1
$288K Sell
16,250
-13,500
-45% -$213K 0.06% 258
2014
Q4
$394K Buy
29,750
+7,550
+34% +$96.5K 0.08% 227
2014
Q3
$262K Hold
22,200
0.06% 246
2014
Q2
$283K Hold
22,200
0.07% 239
2014
Q1
$300K Hold
22,200
0.07% 223
2013
Q4
$267K Hold
22,200
0.09% 213
2013
Q3
$261K Sell
22,200
-167
-0.7% -$1.81K 0.1% 197
2013
Q2
$207K Buy
+22,367
New +$190K 0.09% 212

Other funds holding BSX

Smith Hayes Advisers's BSX Position: Q1 2016 in Review

Smith Hayes Advisers held its Boston Scientific (BSX) position steady in Q1 2016 at 17,910 shares worth $337K. The position accounts for 0.07% of the portfolio, ranked #240.

Smith Hayes Advisers first reported a position in BSX in Q2 2013 and has held it in 12 quarters since. The position peaked at $394K in Q4 2014. 491 funds tracked by Wall St. Rank hold BSX as of Q1 2016.

  • Smith Hayes Advisers held 17,910 shares of Boston Scientific worth $337K as of Q1 2016.
  • Smith Hayes Advisers left its Boston Scientific share count unchanged in Q1 2016.
  • Boston Scientific made up 0.07% of Smith Hayes Advisers's portfolio in Q1 2016, its #240 holding.
  • Smith Hayes Advisers first reported a position in Boston Scientific in Q2 2013 and has held it in 12 quarters since.
  • Smith Hayes Advisers's Boston Scientific position peaked at $394K in Q4 2014.
  • 491 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.